DE69812079D1 - Verfahren zur herstellung eines buthylthuio-isochinolinderivates und zwischenprodukte dafür - Google Patents
Verfahren zur herstellung eines buthylthuio-isochinolinderivates und zwischenprodukte dafürInfo
- Publication number
- DE69812079D1 DE69812079D1 DE69812079T DE69812079T DE69812079D1 DE 69812079 D1 DE69812079 D1 DE 69812079D1 DE 69812079 T DE69812079 T DE 69812079T DE 69812079 T DE69812079 T DE 69812079T DE 69812079 D1 DE69812079 D1 DE 69812079D1
- Authority
- DE
- Germany
- Prior art keywords
- buthylthuio
- isochinoline
- derivative
- producing
- intermediate products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000013067 intermediate product Substances 0.000 title 1
- 150000002537 isoquinolines Chemical class 0.000 title 1
- GKVJSYYVNPXJRL-UHFFFAOYSA-N 1-(4-phenylsulfanylbutyl)isoquinoline Chemical compound N=1C=CC2=CC=CC=C2C=1CCCCSC1=CC=CC=C1 GKVJSYYVNPXJRL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97810212 | 1997-04-10 | ||
EP97810240 | 1997-04-18 | ||
PCT/EP1998/001959 WO1998045271A1 (en) | 1997-04-10 | 1998-04-03 | Process for making a butylthio-isoquinoline and intermediates therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69812079D1 true DE69812079D1 (de) | 2003-04-17 |
DE69812079T2 DE69812079T2 (de) | 2003-12-18 |
Family
ID=27222866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69812079T Expired - Lifetime DE69812079T2 (de) | 1997-04-10 | 1998-04-03 | Verfahren zur herstellung eines buthylthuio-isochinolinderivates und zwischenprodukte dafür |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0975601B1 (de) |
JP (1) | JP3467043B2 (de) |
AT (1) | ATE234288T1 (de) |
AU (1) | AU7214298A (de) |
CA (1) | CA2286013C (de) |
DE (1) | DE69812079T2 (de) |
DK (1) | DK0975601T3 (de) |
WO (1) | WO1998045271A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2273643A1 (en) * | 1998-06-09 | 1999-12-09 | F. Hoffmann-La Roche Ag | Stereoselective reduction of carbonyl compounds |
US6765109B1 (en) | 1998-06-29 | 2004-07-20 | Roche Colorado Corporation | Preparation of S-aryl-cysteine and its derivatives |
EP1236715B1 (de) * | 1998-06-29 | 2008-10-15 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von S-Aryl-Cystein |
DE60040592D1 (de) | 1999-01-28 | 2008-12-04 | Ajinomoto Kk | Verfahren zur herstellung von alpha-aminoketonen |
US6225307B1 (en) | 1999-03-31 | 2001-05-01 | The Procter & Gamble Company | Viral treatment |
JPWO2002064553A1 (ja) * | 2001-02-14 | 2004-06-10 | 呉羽化学工業株式会社 | ハロゲノアルコール誘導体の製造方法 |
CN1329373C (zh) * | 2003-12-11 | 2007-08-01 | 上海安基生物科技股份有限公司 | (2s.3r)-n-苄氧羰基-3-氨基-1-氯-4-苯硫基-2-丁醇的生产方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
JP3611332B2 (ja) * | 1995-09-26 | 2005-01-19 | 日本たばこ産業株式会社 | アミド誘導体の製造方法及び中間体化合物 |
US5705647A (en) * | 1996-09-05 | 1998-01-06 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
-
1998
- 1998-04-03 EP EP98919219A patent/EP0975601B1/de not_active Expired - Lifetime
- 1998-04-03 WO PCT/EP1998/001959 patent/WO1998045271A1/en active IP Right Grant
- 1998-04-03 AU AU72142/98A patent/AU7214298A/en not_active Abandoned
- 1998-04-03 AT AT98919219T patent/ATE234288T1/de active
- 1998-04-03 CA CA002286013A patent/CA2286013C/en not_active Expired - Fee Related
- 1998-04-03 JP JP54236098A patent/JP3467043B2/ja not_active Expired - Fee Related
- 1998-04-03 DK DK98919219T patent/DK0975601T3/da active
- 1998-04-03 DE DE69812079T patent/DE69812079T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU7214298A (en) | 1998-10-30 |
CA2286013A1 (en) | 1998-10-15 |
ATE234288T1 (de) | 2003-03-15 |
CA2286013C (en) | 2003-07-15 |
DK0975601T3 (da) | 2003-06-16 |
WO1998045271A1 (en) | 1998-10-15 |
DE69812079T2 (de) | 2003-12-18 |
EP0975601A1 (de) | 2000-02-02 |
EP0975601B1 (de) | 2003-03-12 |
JP2000510479A (ja) | 2000-08-15 |
JP3467043B2 (ja) | 2003-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69322708D1 (de) | Neues Verfahren zur Herstellung von 7-(substituierten)-9-[(substistuierter Glycyl)amido]-6-demethyl-6-deoxytetracyclinen | |
DE69822028D1 (de) | Verfahren zur Herstellung eines oxidierten Produkts | |
DE69731835D1 (de) | Verfahren zur herstellung von zwischenprodukten des florfenicols | |
DE69606788D1 (de) | Verfahren zur Herstellung eines modifiziertes Raney-Katalysators | |
ATE199709T1 (de) | Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta- lactonresten | |
DE69812079T2 (de) | Verfahren zur herstellung eines buthylthuio-isochinolinderivates und zwischenprodukte dafür | |
DE69513847T2 (de) | Verfahren zur herstellung von substituierten 3-aminobenzonitrilen | |
ATE277915T1 (de) | Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen | |
DE69635057D1 (de) | Verfahren zur herstellung von campothecinderivate | |
ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
DE60106057D1 (de) | Verfahren zur herstellung von baccatin iii-derivativen | |
ATE229006T1 (de) | Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte | |
ATE325794T1 (de) | Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin | |
ATE282594T1 (de) | Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
ATE188694T1 (de) | Verfahren zur herstellung von benzopyranderivaten | |
DE69605573T2 (de) | Verfahren zur herstellung von benzo(b)thiophenen | |
ATE394374T1 (de) | Verfahren zur herstellung eines indolderivates | |
DE69616801D1 (de) | Eintopfverfahren zur herstellung von 2-oxazolidinonderivate | |
DE59907019D1 (de) | Verfahren zur herstellung von 4,4-dimethyl-5 alpha-cholesta-8,14,24-trien-3 beta-ol und zwischenprodukte im verfahren (i) | |
DE60007137D1 (de) | Verfahren zur herstellung von 2-arylvinylalkylethern und 1,4-diaryl-2-fluor-2-butenen | |
ATE247618T1 (de) | Verfahren zur herstellung von 1,4-diaryl-2-fluor- 1,3-butadien- und 1,4-diaryl-2-fluor-2- butenverbindungen | |
DE69608512T2 (de) | Verfahren zur Herstellung von benzylsubstituierten Rhodaninederivaten | |
DE50203529D1 (de) | Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte | |
ATE215071T1 (de) | Verfahren zur herstellung von prostaglandin e1 | |
DK1163257T3 (da) | Fremgangsmåde til fremstilling af 4,4-dimethyl-3beta-hydroxypregna-8,14-dien-21-carboxylsyreestere og mellemprodukter i fremgangsmåden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |